Performance of TXG 10X Genomics | -45.7% in 12m

Compare TXG with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare 10X Genomics with its related Sector/Index XLV

Compare 10X Genomics with its related Sector/Index XLV

Performance Duell TXG vs XLV

TimeFrame TXG XLV
1 Day -5.32% -0.17%
1 Week -17.4% -2.22%
1 Month -19.2% -4.41%
3 Months -30.4% -0.33%
6 Months -30.3% 6.54%
12 Months -45.7% 4.65%
YTD -46.3% 0.12%
Rel. Perf. 1m -1.30
Rel. Perf. 3m -4.31
Rel. Perf. 6m -3.06
Rel. Perf. 12m -6.17

Is 10X Genomics a good stock to buy?

No, based on ValueRay Fundamental Analyses, 10X Genomics (NASDAQ:TXG) is currently (April 2024) a stock to sell. It has a ValueRay Fundamental Rating of -6.01 and therefor a negative outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of April 2024 is 23.93. This means that TXG is currently overvalued and has a potential downside of -17.94%.

Is TXG a buy, sell or hold?

  • Strong Buy: 8
  • Buy: 3
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
10X Genomics has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy TXG.
Values above 0%: TXG is performing better - Values below 0%: TXG is underperforming

Compare TXG with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -14.78% -16.78% -45.94% -68.37%
US NASDAQ 100 QQQ -14.56% -16.52% -46.42% -80.15%
US Dow Jones Industrial 30 DIA -15.58% -16.53% -42.38% -58.89%
German DAX 40 DBXD -15.57% -18.25% -46.69% -57.65%
UK FTSE 100 ISFU -15.56% -19.03% -36.57% -49.93%
Shanghai Shenzhen CSI 300 CSI 300 -19.56% -17.41% -28.95% -28.36%
Hongkong Hang Seng HSI -11.45% -9.89% -16.85% -18.31%
Japan Nikkei 225 EXX7 -13.59% -13.73% -43.83% -64.08%
India NIFTY 50 INDA -15.03% -19.71% -44.17% -73.30%
Brasil Bovespa EWZ -11.47% -13.49% -32.28% -55.29%

TXG 10X Genomics vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -14.97% -18.26% -47.84% -82.74%
Consumer Discretionary XLY -13.91% -15.44% -37.17% -63.09%
Consumer Staples XLP -16.17% -16.42% -40.21% -45.52%
Energy XLE -13.68% -22.46% -35.45% -58.68%
Financial XLF -14.49% -16.29% -49.05% -67.16%
Health Care XLV -15.20% -14.77% -36.86% -50.35%
Industrial XLI -15.02% -18.55% -48.74% -68.08%
Materials XLB -14.57% -17.37% -43.93% -57.28%
Real Estate XLRE -12.47% -11.34% -35.67% -44.56%
Technology XLK -14.56% -15.57% -48.12% -80.07%
Utilities XLU -16.28% -20.52% -39.47% -41.39%
Aerospace & Defense XAR -15.24% -16.08% -43.17% -59.84%
Biotech XBI -11.53% -10.25% -50.75% -49.17%
Homebuilder XHB -13.97% -15.46% -64.48% -95.63%
Retail XRT -13.74% -12.87% -46.43% -60.39%

TXG 10X Genomics vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -13.55% -20.37% -30.46% -57.09%
Natural Gas UNG -9.19% -12.92% 19.61% 3.88%
Gold GLD -19.27% -28.96% -53.48% -64.06%
Silver SLV -18.99% -32.01% -53.89% -57.99%
Copper CPER -19.10% -24.73% -52.80% -54.72%

Returns of TXG vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -16.38% -15.86% -37.11% -34.87%
iShares High Yield Corp. Bond HYG -16.50% -17.78% -38.26% -52.85%
Does 10X Genomics outperform its market, is TXG a Sector Leader?
No, over the last 12 months 10X Genomics (TXG) made -45.70%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 4.65%.
Over the last 3 months TXG made -30.41%, while XLV made -0.33%.
Period TXG XLV S&P 500
1 Month -19.18% -4.41% -2.40%
3 Months -30.41% -0.33% 6.31%
12 Months -45.70% 4.65% 22.67%